CABP Trial Guidance Snarls Advanced Life Sciences Cethromycin: FDA Panel Votes Against Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Company says it remains committed to developing Restanza for community acquired bacterial pneumonia.